Search results

Articles (4)

Journals (0)

1-4 of 4 results for ADS-5102

Sort by:

Relevance

Select all

Sort by:

Relevance

Open accessResearch articleFirst published April, 2019

Safety and efficacy of ADS-5102 (amantadine) extended release capsules to improve walking in multiple sclerosis: A randomized,placebo-controlled,phase 2 trial

Jeffrey A Cohen, Samuel F Hunter, Theodore R Brown [...]

Multiple Sclerosis Journal

Open accessResearch articleFirst published April, 2022

A Phase 3,double-blind,placebo-controlled efficacy and safety study of ADS-5102 (Amantadine) extended-release capsules in people with multiple sclerosis and walking impairment

Jeffrey A Cohen, Michelle H Cameron, Myla D Goldman [...]

Multiple Sclerosis Journal

Open accessResearch articleFirst published August 8, 2017

ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson’s Disease (EASE LID 2 Study): Interim Results of an Open-Label Safety Study

Robert A. Hauser, Rajesh Pahwa, Caroline M. Tanner [...]

Journal of Parkinson’s Disease

Restricted accessResearch articleFirst published December, 2012

The 5.1 ka aridization event,expansion of piñon-juniper woodlands,and the introduction of maize ( Zea mays ) in the American Southwest

Brandon L Drake, WH Wills, Erik B Erhardt

The Holocene

Search results

Articles (4)

Journals (0)

1-4 of 4 results for ADS-5102

Sort by:

Relevance

Select all

Sort by:

Relevance

Open accessResearch articleFirst published April, 2019

Safety and efficacy of ADS-5102 (amantadine) extended release capsules to improve walking in multiple sclerosis: A randomized,placebo-controlled,phase 2 trial

Jeffrey A Cohen, Samuel F Hunter, Theodore R Brown [...]

Multiple Sclerosis Journal

Open accessResearch articleFirst published April, 2022

A Phase 3,double-blind,placebo-controlled efficacy and safety study of ADS-5102 (Amantadine) extended-release capsules in people with multiple sclerosis and walking impairment

Jeffrey A Cohen, Michelle H Cameron, Myla D Goldman [...]

Multiple Sclerosis Journal

Open accessResearch articleFirst published August 8, 2017

ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson’s Disease (EASE LID 2 Study): Interim Results of an Open-Label Safety Study

Robert A. Hauser, Rajesh Pahwa, Caroline M. Tanner [...]

Journal of Parkinson’s Disease

Restricted accessResearch articleFirst published December, 2012

The 5.1 ka aridization event,expansion of piñon-juniper woodlands,and the introduction of maize ( Zea mays ) in the American Southwest

Brandon L Drake, WH Wills, Erik B Erhardt

The Holocene